These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2141109)
1. L-carnitine and platelet aggregation in uremic patients subjected to hemodialysis. Bellinghieri G; Savica V; Barbera CM; Ricciardi B; Egitto M; Torre F; Valentini G; D'Iddio S; Bagiella E; Mallamace A Nephron; 1990; 55(1):28-32. PubMed ID: 2141109 [TBL] [Abstract][Full Text] [Related]
2. High dose of L-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialysis. Weschler A; Aviram M; Levin M; Better OS; Brook JG Nephron; 1984; 38(2):120-4. PubMed ID: 6472539 [TBL] [Abstract][Full Text] [Related]
3. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis. Guarnieri GF; Ranieri F; Toigo G; Vasile A; Ciman M; Rizzoli V; Moracchiello M; Campanacci L Am J Clin Nutr; 1980 Jul; 33(7):1489-92. PubMed ID: 7395772 [TBL] [Abstract][Full Text] [Related]
4. [Effects of L-carnitine on erythropoiesis and blood platelet aggregation in patients with chronic renal failure treated with hemodialysis]. Kalinowski M; Popławski A; Mazerska M; Daniluk A Pol Merkur Lekarski; 1999 Feb; 6(32):76-8. PubMed ID: 10337176 [TBL] [Abstract][Full Text] [Related]
5. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia. Elshamaa MF; Elghoroury EA; Helmy A Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197 [TBL] [Abstract][Full Text] [Related]
6. Carnitine depletion as a probable cause of hyperlipidemia in uremic patients on maintenance hemodialysis. Maebashi M; Imamura A; Yoshinaga K; Sato T; Funyu T; Ishidoya Y; Hirayama N Tohoku J Exp Med; 1983 Jan; 139(1):33-42. PubMed ID: 6836557 [TBL] [Abstract][Full Text] [Related]
7. Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects. Golper TA; Wolfson M; Ahmad S; Hirschberg R; Kurtin P; Katz LA; Nicora R; Ashbrook D; Kopple JD Kidney Int; 1990 Nov; 38(5):904-11. PubMed ID: 2266674 [TBL] [Abstract][Full Text] [Related]
8. Platelets and antithrombin III in uraemia: the acute effect of haemodialysis. Knudsen F; Dyerberg J Scand J Clin Lab Invest; 1985 Jun; 45(4):341-7. PubMed ID: 3160101 [TBL] [Abstract][Full Text] [Related]
9. Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma. Zwaginga JJ; IJsseldijk MJ; de Groot PG; Kooistra M; Vos J; van Es A; Koomans HA; Struyvenberg A; Sixma JJ Thromb Haemost; 1991 Dec; 66(6):638-47. PubMed ID: 1665596 [TBL] [Abstract][Full Text] [Related]
10. Effect of oral carnitine supplementation on disturbances of lipid metabolism in the uremic rat. Basile C; Lacour B; Di Giulio S; Drüeke T Nephron; 1985; 39(1):50-4. PubMed ID: 3969191 [TBL] [Abstract][Full Text] [Related]
11. The coagulative system in haemodialyzed patients: the relationship between the elderly and hypertrygliceridaemia. Savica V; Bellinghieri G; Barbera CM; Egitto M; Consolo F Arch Ital Urol Nefrol Androl; 1992 Jun; 64(2):155-63. PubMed ID: 1387242 [TBL] [Abstract][Full Text] [Related]
12. Effect of dialysate composition on the lipid response to L-carnitine supplementation. Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997 [TBL] [Abstract][Full Text] [Related]
13. Influence of L-carnitine supplementation on serum lipid profile in hemodialysis patients: a systematic review and meta-analysis. Huang H; Song L; Zhang H; Zhang H; Zhang J; Zhao W Kidney Blood Press Res; 2013; 38(1):31-41. PubMed ID: 24525835 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of platelet aggregation disturbances and their relation to treatment in patients with chronic uremia. Komarnicki M; Pietrzak I Int J Artif Organs; 1988 Mar; 11(2):91-4. PubMed ID: 3131259 [TBL] [Abstract][Full Text] [Related]
15. Platelet function in patients on maintenance hemodialysis: depressed or enhanced? Remuzzi G; Benigni A; Dodesini P; Schieppati A; Gotti E; Livio M; Mecca G; Donati B; de Gaetano G Clin Nephrol; 1982 Feb; 17(2):60-3. PubMed ID: 7067167 [TBL] [Abstract][Full Text] [Related]
16. [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients]. Dionisio P; Bergia R; Caramello E; Graziola M; Valenti M; Bajardi P; Barbera L; Voglino F Minerva Med; 1985 Feb; 76(6):229-34. PubMed ID: 3974937 [TBL] [Abstract][Full Text] [Related]
17. [Some parameters of platelet activation in patients with uremia before and after hemodialysis (HD)]. Dymicka-Piekarska V; Matowicka-Karna J; Mantur M; Kemona H; Piszka J Przegl Lek; 2002; 59(12):980-3. PubMed ID: 12731371 [TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: interactions between platelet aggregation, blood lipids and age. Yamanishi J; Sano H; Saito K; Furuta Y; Fukuzaki H Thromb Haemost; 1985 Aug; 54(2):539-43. PubMed ID: 2417354 [TBL] [Abstract][Full Text] [Related]
20. [Results of a multicenter study on the effect on serum triglycerides and cholesterol administration of carnitine in chronic uremia patients undergoing periodic hemodialysis treatment]. Toigo G; Situlin R; Dardi F; Bazzato G; Vasile A; Tesio F; Ciman M; Guarnieri GF G Clin Med; 1982; 63(11-12):841-9. PubMed ID: 7182204 [No Abstract] [Full Text] [Related] [Next] [New Search]